WeedMD Appoints Canadian Entrepreneur Bruce Croxon to Board of Directors and Reports Results of AGM
Bruce Croxon is a prominent Canadian entrepreneur and venture capitalist and co-founder of Lavalife.
WeedMD Partners with CannTx Life Sciences to Enhance Genetics Bank of New Cultivars and Preserve its Elite Proprietary Cannabis Strains
University of Guelph-affiliated company to provide WeedMD with innovative tissue cultured-plant services via Steadystem Solutions for cloning accuracy and plant asset preservation
WeedMD Reports First Quarter 2020 Financial Results and Posts Record Revenue of $12.2 Million
WeedMD announced today its financial results for the three months ended March 31, 2020.
WeedMD Cultivars Included in UHN-led Chronic Pain Study
Company’s products on ‘Medical Cannabis by Shoppers’ platform, registered under blockchain-enabled program added to University Health Network’s research trials
WeedMD Announces Amendments to Existing Credit Facility
Amendments to the terms of the Company’s $39 million senior secured credit facility provide WeedMD with greater financial flexibility
WeedMD Reaffirms Record Q1 2020 Preliminary Net Revenues of $12 Million and Confirms Earnings Call on July 15, 2020
Sequential 325% quarter-over-quarter growth signals strong demand and brand recognition
WeedMD Launches Cannabis 2.0 Product Line of Medical Vaporizers
Strain-specific ‘Aurum’ vapes produced in-house at Company’s CX Industries’ facility expands Company’s medical product portfolio
WeedMD Launches Same-Day Medical Cannabis Delivery Service
Pilot project ‘PatientDirect’ kicks off in June with express delivery to Toronto-area patients
WeedMD Completes Planting Cannabis on its 27-Acre Outdoor Field and Provides Operational Update on CX Industries
Kicks-off second-year outdoors with over 18,000 plants slated for fall harvest, confirms 2019 outdoor biomass now in extraction for new cannabis formats at CX Industries
WeedMD Reports Fiscal Year 2019 Financial Results and First Quarter 2020 Preliminary Revenue of $12 Million
WeedMD announced today its financial results for the fiscal year ended December 31, 2019, including a 162% net revenue increase to $20.8 million, compared with $8.0 million for the prior year.
WeedMD to File First Quarter 2020 Financials on or Before July 15
WeedMD announced today that it will file its financial statements for the first quarter ended March 31, 2020 on or before July 15, 2020.
WeedMD Realigns Reporting Dates and Confirms Fiscal Year 2019 Financials to be Filed After Market on June 10, 2020
The Company will host a conference call on Thursday, June 11, 2020, at 10 a.m. ET.
WeedMD to Present in Canaccord Genuity’s 4th Annual Global Cannabis Virtual Conference on May 12th at 8:40 a.m. ET
WeedMD is pleased to announce that Angelo Tsebelis, Chief Executive Officer and Stephen Ng, Chief Commercial Officer, will be presenting in Canaccord Genuity’s 4th Annual Global Cannabis Virtual Conference.
WeedMD to Report its Fiscal Year 2019 Financials on May 27, 2020
Company provides corporate update including COVID-19 impact and confirms earnings conference call will be held on Thursday, May 28, 2020 at 10 a.m. Eastern Time
WeedMD Kicks-off Second Season of Outdoor Cannabis Cultivation
Primes 27-acres in Strathroy, ON for early June 2020 planting and fall harvest
WeedMD Responds to UFCW Canada
WeedMD issued the following public statement in response to the United Food and Commercial Workers Union (“UFCW Canada”) public notification.
WeedMD Announces Appointment of New Chief Financial Officer
Lincoln Greenidge brings over 20 years of corporate finance, M&A, capital markets and operations experience to the WeedMD team
WeedMD Subsidiary Starseed Medicinal Signs the International Association of Heat and Frost Insulators and Allied Workers Local 95 to its Medical Cannabis Program
Starseed is now the preferred medical cannabis supplier to the Insulators Local 95 Health & Welfare Trust Fund through their benefits program
WeedMD Subsidiary Starseed Medicinal Signs the International Union of Painters and Allied Trades to Medical Cannabis Program
Starseed is now the preferred medical cannabis supplier to IUPAT Province of Ontario Health & Welfare Trust Fund through their benefits program
WeedMD Subsidiary Starseed Medicinal Secures Cannabis Research Licence from Health Canada
New licence allows for ongoing product development and the evaluation of cannabis concentrates in portable vaporizer devices for optimal formulations